Labopharm Inc. (DDSS) Stock Falls
Labopharm Inc. (NASDAQ:DDSS - News) shares fall after the company said it's received an approvable letter from the Food and Drug Administration related to its once-daily formulation of tramadol that says the application is approvable subject to the resolution of certain undisclosed issues. The Canadian company said it plans to discuss the letter with the FDA as soon as possible, and it believes it can address the issues without the need for additional data.
posted by Stock Administrator @ 4:05 PM
0 Comments:
Post a Comment
<< Home